TCL Archive NCI Advisors Criticize a Biomarker Study Touted as High Priority for NCI and FDA. July 13, 2007
TCL Archive ASCO’s Lichter Says. Dingell, Stupak Urge FDA To “Act With Due Haste To Avoid Endangering Patients” Steered To ESAs. March 7, 2008
TCL Archive Drug Approvals: FDA grants accelerated approval for Keytruda in metastatic melanoma September 5, 2014
